Endocrine Abstracts

Background: There are a variety of growth hormone delivery devices (GHDD) available to children requiring growth hormone (GH) therapy. Many paediatric endocrine nurses can offer patients and their families a choice of the products that are available, which can sometimes be overwhelming. However, factors such a licenced clinical indications have to be considered, as well as cost. This study explored nurses viewpoints on GHDD.Aim: The purpose of this proje...

Background and aims: Non-adherence to daily subcutaneous GH (r-HGH) administration may account for discrepancies between dose prescription, growth response and serum IGF1 levels but is difficult to determine. The electronic r-HGH auto-injector Easypod device has the only inbuilt retrievable dosing record, with which we aimed to assess adherence.Method: Over a 4 month period, we retrospectively retrieved dose history data in 25 clinic patients aged 10&#15...

Introduction: Strategies for optimising adherence in patients with growth hormone disorders often focus on enabling them to achieve autonomy in the management of their treatment, including self-injection of growth hormone (GH). However, there is a scarcity of published data on the effectiveness of this approach. We conducted a survey to elicit responses from UK endocrinologists and endocrine nurses, to investigate ‘real-world’ clinical practices around the initiation...